Skip to main content
Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
3.850
+0.280 (7.84%)
At close: Nov 20, 2024, 4:00 PM
3.640
-0.210 (-5.45%)
After-hours: Nov 20, 2024, 7:21 PM EST

Biodexa Pharmaceuticals Revenue

Biodexa Pharmaceuticals had revenue of 83.00K GBP in the twelve months ending June 30, 2024, down -84.31% year-over-year. In the year 2023, Biodexa Pharmaceuticals had annual revenue of 381.00K, down -45.49%.

Revenue (ttm)
83.00K GBP
Revenue Growth
-84.31%
P/S Ratio
7.00
Revenue / Employee
3,952 GBP
Employees
21
Market Cap
2.24M USD

Revenue Chart

* This company reports financials in GBP.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023381.00K-318.00K-45.49%
Dec 31, 2022699.00K121.00K20.93%
Dec 31, 2021578.00K235.00K68.51%
Dec 31, 2020343.00K-331.00K-49.11%
Dec 31, 2019674.00K-1.26M-65.22%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Venus Concept 67.20M
Xylo Technologies 57.64M
Scorpius Holdings 10.04M
Akanda 2.51M
HeartSciences 18.60K
Revenue Rankings

BDRX News

More News